RPG Life Sciences: To continue moving towards Life time high
- RPG Life Sciences: To continue moving towards Life time high
- For the full fiscal year FY24 too, the company achieved a 29% year-on-year increase in PAT
- Saw an expansion of EBITDA margin from 21.0% to 23.3% year-on-year.
- Revenue from operations, totaling Rs 582.05 crores, experienced a 14% Y-O-Y growth for FY24.
- Top priority, Domestic Formulations, the biggest contributor to the Company’s business, recorded robust growth in both value and volume
- To enter other specialties like Gastro and Derma to emerge as future growth drivers of Domestic Formulations business
- Structural approach of cost optimization has helped explore newer avenues in operations to achieve cost efficiencies, helping to maintain 5-year uninterrupted Y-o-Y margin expansion trajectory for the past 5 consecutive years
Comments
Post a Comment